Next Article in Journal
Environmental, Ecological, and Economic Benefits of Biofuel Production Using a Constructed Wetland: A Case Study in China
Next Article in Special Issue
Tai Chi as an Alternative Exercise to Improve Physical Fitness for Children and Adolescents with Intellectual Disability
Previous Article in Journal
Pulmonary Fibrosis among World Trade Center Responders: Results from the WTC Health Registry Cohort
Previous Article in Special Issue
The Effects of Tai Chi on Markers of Atherosclerosis, Lower-limb Physical Function, and Cognitive Ability in Adults Aged Over 60: A Randomized Controlled Trial
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJERPH
Volume 16
Issue 5
10.3390/ijerph16050826
ijerph-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Qigong-Based Therapy for Treating Adults with Major Depressive Disorder: A Meta-Analysis of Randomized Controlled Trials

by
Lijuan Guo
1,
Zhaowei Kong
2 and
Yanjie Zhang
3,*
1
College of Physical Education, Shanxi Normal University, Linfen 041000, China
2
Faculty of Education, University of Macau, Macau, China
3
Health and Exercise Science Laboratory, Institute of Sports Science, Seoul National University, Seoul 08826, Korea
*
Author to whom correspondence should be addressed.
Int. J. Environ. Res. Public Health 2019, 16(5), 826; https://doi.org/10.3390/ijerph16050826
Submission received: 9 February 2019 / Revised: 26 February 2019 / Accepted: 27 February 2019 / Published: 7 March 2019
(This article belongs to the Special Issue Mindfulness-Based Practice for Health Benefits)
Browse Figures
Versions Notes

Abstract

:
This current meta-analysis review was conducted to examine the effectiveness of Qigong-based therapy on individuals with major depressive disorder. Six electronic databases (PubMed, PsycINFO, Cochrane Library, and Web of Science, Chinese National Knowledge Infrastructure, and Wangfang) were employed to retrieve potential articles that were randomized controlled trials. The synthesized effect sizes (Hedges’ g) were computerized to explore the effectiveness of Qigong-based therapy. Additionally, a moderator analysis was performed based on the control type. The pooled results indicated that Qigong-based therapy has a significant benefit on depression severity (Hedges’ g = −0.64, 95% CI −0.92 to −0.35, p < 0. 001, I2 = 41.73%). Specifically, Qigong led to significantly reduced depression as compared to the active control groups (Hedges’ g = −0.47, 95% CI −0.81 to −0.12, p = 0.01, I2 = 22.75%) and the passive control groups (Hedges’ g = −0.80, 95% CI −1.23 to −0.37, p < 0.01, I2 = 48.07%), respectively. For studies which reported categorical outcomes, Qigong intervention showed significantly improved treatment response rates (OR = 4.38, 95% CI 1.26 to 15.23, p = 0.02) and remission rates (OR = 8.52, 95% CI 1.91 to 37.98, p = 0.005) in comparison to the waitlist control group. Conclusions: Qigong-based exercises may be effective for alleviating depression symptoms in individuals with major depressive disorder. Future well-designed, randomized, controlled trials with large sample sizes are needed to confirm these findings.

1. Introduction

Clinical depression, also referred to as major depressive disorder (MDD), is a common debilitating mental disorder and is a leading cause of disability [1]. In fact, according to the statistics of the World Health Organization, there are more than 300 million individuals with MDD worldwide [2]. Patients with MDD often receive various forms of treatment (i.e., psychotherapy, pharmaceutics (antidepressants), or a combination of these two first-line therapies) [3]. Although these treatments have been shown to have therapeutic effects for those with MDD [4,5], they are subject to several limitations, such as high dropout rates (e.g., 12–40% during an 8-week psychotherapy), low remission rates, and numerous medication-related side effects (e.g., nausea, diarrhea, excessive sedation, and sleep problems) [6,7,8]. Considering the drawbacks of these first-line therapies, alternative and complementary therapies are needed to be developed to treat MDD [9].
Qigong is a traditional, self-healing, mind–body therapy that originated from traditional Chinese medicine (TCM), dating back to nearly four thousand years ago [10,11,12]. The term Qigong consists of two Chinese characters: Qi (vital energy) and Gong (skill acquisition through great effort) [13,14]. According to the textbook used in TCM schools in China, Qigong encompasses all mind–body exercises and skills that integrate breathing adjustment, body adjustment, and mind adjustment into one [15]. Aside from medical Qigong, Qigong is commonly categorized into two practice modalities: Movement Qigong and static Qigong [16]. Movement Qigong involves mind–body exercises that incorporate bodily movements or postures with breathing regulation and mind adjustment, such as Tai Chi (Taiji) Quan, Baduanjin, Muscle–Tendon Change Classic (Yi Jin Jing), and Five Animal Exercise (Wu Qin Xi) [17,18,19,20,21,22]. Static Qigong mostly involves meditative practices (Zen meditation or mindfulness) in either a sitting or standing posture, and does not include any bodily movement [23].
Qigong has gained increasing popularity across the globe and has been widely practiced by individuals with different health conditions since the development of the Chinese National Qigong Association in 2004 [24,25]. Of note, the National Health Interview Survey showed that both movement and static Qigong have been considered to be one of the most popular mindfulness-based exercises (e.g., Qigong and Yoga) in the US workforce, and more than 130 million people engaged in at least one of these exercises in the past 12 months [26]. According to the TCM principle, Qi (a subtle energy) exists in all life and circulates through multiple meridian systems in the human body, like neuropathways [27]. Subsequently, a free-flowing, well-balanced Qi system is believed to help people stay healthy, and physical or mental illnesses are said to occur as a result of a Qi blockage in some regions of the human body [27]. Therefore, Qigong, as a Chinese traditional therapy, is believed to break Qi blockages and help Qi flow smoothly, which may potentially prevent or decelerate the progression of psychosomatic illnesses [27]. The literature also suggests that Qigong is effective in improving disease-related symptoms in people with different illnesses and chronic conditions (e.g., multiple sclerosis, stroke, ankylosing spondylitis, osteoporosis, and chronic musculoskeletal pain) [28,29,30,31].
Although recent reviews have investigated the therapeutic effects of Qigong practice on mood regulation, such as depression and anxiety [32,33,34,35], it is unclear whether the recruited participants were clinically diagnosed with MDD. To this end, it is impossible to single out whether Qigong is effective in treating MDD based on recent reviews. The current systematic review is, therefore, conducted to critically evaluate the efficacy of Qigong-based therapy among patients who are clinically diagnosed with MDD. The results of this review shall provide evidence-based guidance for clinicians and health professionals to use or integrate Qigong therapy with other mainstream therapies for treating MDD.

2. Materials and Methods

This meta-analysis review was performed consistent with the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) guidelines [36].

2.1. Information Sources and Search

The review author systematically searched six major electronic databases (PubMed, PsycINFO, Cochrane Library, Web of Science, Chinese National Knowledge Infrastructure, and Wanfang) and included no restrictions on the date of publication. The literature search was performed by entering three groups of terms: (1) Qigong/Qi Gong, Baduanjin, Tai Chi/Tai Ji, Taiji Quan, Zhuang Gong, Chi Kung, Chi therapy, Wu Qin Xi, Chan, Zen, Tai Chi, meditation, or mindfulness; (2) major depression, clinical depression, depressive disorder, or unipolar depression; and (3) randomized, randomization, or randomized controlled trial. Furthermore, we also manually searched the potentially relevant studies provided in the reference lists of relevant reviews.

2.2. Eligibility Criteria and Study Selection

Inclusion criteria for identified articles were studies that: (1) were published in peer-reviewed journals; (2) used a randomized controlled design; (3) included patients aged 18 or above who had been diagnosed with MDD; (4) used any form of Qigong as a core intervention; (5) had a passive or active control group as a comparison, such as a waitlist, usual care, pharmacological therapy, or walking; and (6) reported either response rate, remission rate, and/or depression severity. The exclusion criteria were: (1) individuals diagnosed with other primary psychiatric disorders (e.g., major anxiety disorder) or mild cognitive impairment; (2) conference proceedings, case-studies, cross-sectional studies, controlled studies with no randomization or review; (3) non-Qigong interventions; and (4) duplicated publications.
Regarding study selection, removing both irrelevant and duplicate articles was conducted by an investigator screening the titles and abstracts. Two investigators then independently conducted full-text reviews to screen the remaining articles. All disagreements between the two investigators were resolved by seeking a third party’s viewpoint.

2.3. Data Extraction

The following information was extracted to a data extraction table: Reference (first author and year of publication), participant characteristics (diagnostic criteria, percentage of MMD, study location, sample size, dropout rate, percentage of female participants, ethnicity, and mean age), intervention protocol (Qigong type, group or individual practice, qualification of instructor, intervention duration and follow-up period, training dosage, Qigong-related adverse events, and co-intervention), outcome measures, and study quality (allocation concealment, intention-to-treat analysis, and blinding of assessors) [37]. Quantitative data were extracted as well, including the sample size, mean and standard deviation (SD) of outcome measures at baseline and post-intervention in each group.

2.4. Study Quality Assessment

Three critical items (allocation concealment, intention-to-treat analysis, and blinding of assessors) were employed to assess the methodological quality of the selected studies based on the existing literature [38,39]. Since poor randomization methods can exaggerate estimated treatment effects [40], the implementation of allocation concealment is critical. The allocation concealment is adequate if the central randomization (site remote from study location) or opaque sequentially-numbered envelopes were clearly described. A study was identified as an intention-to-treat analysis if all of the initially assigned participants in each group were included in the final data analysis, regardless of missing data or dropout during/after the intervention. Blinding means that people who performed the outcome assessments did not possess information about group allocation of the study participants.

2.5. Quantitative Data Synthesis and Analysis

The Comprehensive Meta-Analysis Version 2 Software (BioStat, Englewood, NJ, USA) was employed to perform the data synthesis. The synthesized effect size (Hedges’ g), which expresses the magnitude of Qigong effects on the severity of depressive symptoms, was calculated with a 95% confidence interval (CI). The magnitude of Hedges’ g was then classified as being either a small, medium, or large effect (small effect = 0.2, medium effect = 0.5, large effect = 0.8), with a negative value indicating lower depression severity due to the beneficial effects of Qigong in comparison to the control groups. Odds ratios (OR) with 95% CIs were calculated for both response rates and remission rates. Since the measuring instruments across the selected studies were different, a random-effects model was adopted. Study heterogeneity was assessed using the value of I-squared and were divided into three levels (low = 25% or below; medium = 25% to 50%; large = 75% to 100%) [37].
There were two trials that included more than one control group [41,42]. To reduce the unit-of-analysis error, the shared Qigong group was separated into two controls for the two comparisons, while the means and SD of the Qigong group were unchanged. In addition, the Beck Depression Inventory (BDI) and the 17-item Hamilton Depression Rating Scale (HAM-D17) were used to measure the depression severity in two trials [41,42]. Given that the HAM-D17 is the clinician-administered depression assessment scale [43] and the most frequently used instrument in the present review, we only included the quantitative data measured by the HAM-D17 for meta-analysis. Furthermore, control type may be a potential moderator that also has an influence on the outcomes. Therefore, we performed two comparisons (Qigong vs. active control and Qigong vs. passive control) of the meta-analysis separately. Finally, the Egger’s test was applied to evaluate the publication bias [44].

3. Results

3.1. Study Selection and Characteristics

Figure 1 depicts the detailed process of study selection. A total of 609 records were initially identified, seven randomized controlled trials with nine-arm were included for synthesized analysis [41,42,45,46,47,48,49]. As shown in Table 1, the seven trials were published between 2004 and 2017. Within the trials altogether, there were 382 patients with MDD in either the Qigong group (n = 175) or control group (n = 207). The holistic trials were distributed in the USA (n = 3), China (n = 2), United Kingdom (n = 1), and Germany (n = 1). The Qigong therapy lasted from 1 to 12 weeks, but only one study used a 12-week follow-up assessment [41]. A group-based training mode was the most frequently used method in the Qigong practice (antidepressant medications and/or psychotherapy allowed), without adverse events reported. Depression severity was measured by four difference scales (HAM-D17, HAM-D24, BDI, and the Epidemiological Studies Depression Scale). Response rate (categorized as >50% improvement on the HAM-D17 score) and remission rate (HAM-D17 scores ≤ 7) were reported in two trials [41,45].

3.2. Quality Assessment

Only two studies met all the three of critical criteria, defined as allocation concealment, intention-to-treat analysis, and blinding of assessors [45,46]. Allocation was adequately concealed in five trials [42,45,46,48,49], four studies [41,45,46,47] were not used intention-to-treat analysis, and assessors were blinded to group assignment in four trials [42,45,46,47].

3.3. Effects of Qigong on Response Rate, Remission Rate, and Depression Severity

There were only two trials reporting response rate and remission rate. Of the two trials, the study by Yeung et al. [45] included a Qigong group and a passive control group, while two control groups (active and passive conditions) were used in the other study [42]. An odds ratio was computed across these two studies and the results showed that the Qigong intervention showed significant improvement in treatment response rate (OR = 4.38, 95% CI 1.26 to 15.23, p = 0.02) and remission rate (OR = 8.52, 95% CI 1.91 to 37.98, p = 0.005) compared with the waitlist control group. There was no significant publication bias for the seven included studies with the nine treatment arms based on the results of Egger’s test (β= −1.25, p = 0.51).
In term of depression severity, the synthesized result indicated that Qigong therapy contributed to a more significant benefit than the control group (Hedges’ g = −0.64, 95% CI −0.92 to −0.35, p < 0. 001, I2 = 41.73%). Moreover, the effects of Qigong significantly reduced depression as compared to the active control group (Hedges’ g = −0.47, 95% CI −0.81 to −0.12, p = 0.01, I2 = 22.75%) and passive control group (Hedges’ g = −0.80, 95% CI −1.23 to −0.37, p < 0.01, I2 = 48.07%), respectively (Table 2). Interestingly, there were two types of Qigong therapy (movement Qigong and static Qigong). The movement Qigong from seven sets of data had the benefit of significantly reducing depression (Hedges’ g = −0.62, 95% CI −0.96 to −0.28, p < 0.01, I2 = 41.62%). The static Qigong showed a marginal significant difference in reducing depression compared with control group (Hedges’ g = −0.67, 95% CI −1.38 to 0.04, p = 0.06, I2 = 67.84%). However, no statistically significant difference between movement Qigong and static Qigong on reducing depression was observed (p = 0.90) (Table 2). Additionally, according to Table 1 and Figure 2, the long Qigong practice time tends to have great benefits in movement Qigong [45,47], and the corresponding training protocols were each exercise session (45–60 min), frequency (2–3 times/week), and exercise duration (12 weeks). In static Qigong (mindfulness) intervention, it indicated that the protocol was fine, if participants persisted for 50 min once a day for two weeks.

4. Discussion

This meta-analytic review was conducted to statistically synthesize the evidence of the effectiveness of Qigong-based therapy on MDD. The findings from our review suggest that the group of TCM mind-body exercise shows some clinical effect in the treatment of MDD as compared to active/passive controls.
In terms of response and remission rates, more than 50% improvement on the HAM-D17 scores and HAM-D17 scores ≤ 7 were identified as positive effect respectively [45]. Results from this meta-analysis indicated that Qigong-based intervention may be significantly beneficial to improve the response and remission rate for MDD compared with the control group (p < 0.05). These results were in line with previous clinical study [41], which agreed that the participants who received 60 min of Tai Chi twice a week for 12 weeks achieved some improvement in their depression than other therapies (i.e., psychoeducation). It is likely that Qigong-based intervention combining intentional bodily movements, rhythmic respiration and mind adjustment can regulate the body’s stress and then reduce depression symptoms [9]. Therefore, depression severity was significantly alleviated in our meta-analytic study. In addition, according to the different Qigong types, movement Qigong had a significant improvement in alleviating the depression (p < 0.01), and there was a marginal significant improvement on depression through practicing static Qigong (p = 0.06). However, the moderate effect sizes of alleviated depression symptoms were tentative because of including a small number of eligible studies in this current review. Further studies were needed to examine the efficacy of either movement Qigong or static Qigong or both Qigong styles on treating MDD.
Although Qigong-based intervention has a potential impact on clinical and public health, the exact mechanisms of how Qigong works in reducing MDD are unknown, using Qigong as an important adjunct therapy for treatment of MDD was positively effective based on the findings from this study. A contemporary concept hypothesizes that Qigong practitioners are able to combine their awareness of spirit with body posture, breathing, and activity to elevate physiological proprioception. Furthermore, it can enhance homeostasis of the internal environment [50]. There are a lot of advantages of using Qigong exercises, compared to the current first-line treatments (drugs and cognitive behavioral therapy), as an alternative method for treating individuals with MDD. Qigong exercises are characterized as easy to learn, and have few side effects, and are popular in a number of people across all ages and physical condition. In particular, Qigong exercise is an additional option for older adults with medication side effects. However, there are some potential disadvantages in actual life, such as a lack of qualified Qigong instructors in some places, non-standardized Qigong exercises, and non-adherence to long-term practices.
Several methodological limitations need to be noted. First, the subjective bias may exist in participants. Although eligible randomized controlled trials were included, participants still knew the allocation of the intervention (i.e., if they received Qigong training or not). Second, in most studies, participants were given mixed treatment, such as a combination of medication and Qigong. To some extent, it is difficult to determine if the Qigong alone, both Qigong and medication (synergetic intervention effect), or the usual treatment can contribute to alleviating their symptoms. However, significant effects of Qigong, as a complementary therapy, were observed to treat depressive disorder in this current study. Third, as large spans of time of Qigong practice were employed in the included studies, an optimal Qigong prescription was not easy to recommend for patients. It is possible that Qigong provides a number of benefits for human health based on practitioners daily self-practice, such as movement Qigong (45–60 min, 2–3 times/week) and static Qigong (50 min, once a day). Lastly, it is an interest point that, as both types of Qigong were effective through integrating a small number of studies, future studies may investigate whether the combination of movement Qigong and static Qigong are effective for MDD.

5. Conclusions

Our meta-analysis results suggest that Qigong may be an effective complementary intervention to treat individuals with MDD. Participants may practice movement Qigong for 45–60 min, two to three times weekly, for 12 weeks, and practice static Qigong for 50 min every day in a clinic. As there are some methodological limitations in the empirical studies included, carefully interpreting these findings is required. Meanwhile, to further investigate the efficacy of Qigong-based intervention on MDD, it is necessary to study the quality of randomized controlled trails with well-researched design.

Author Contributions

L.G. and Y.Z. contributed to the conception and design of the review. L.G. applied the search strategy. Z.K. and Y.Z. applied the selection criteria. L.G., Z.K., and Y.Z. completed the assessment of risk of bias. Z.K. and Y.Z. analyzed the data and interpreted data. Z.K. and Y.Z. drafted this manuscript. All authors edited this manuscript.

Funding

This research received no external funding.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Bentley, S.M.; Pagalilauan, G.L.; Simpson, S.A. Major Depression. Med. Clin. N. Am. 2014, 98, 981–1005. [Google Scholar] [CrossRef] [PubMed]
  2. World Health Organization. Depression: Let’s Talk Says WHO, as Depression Tops Lists of Causes of Ill Health. Available online: http://www.who.int/mediacentre/news/releases/2017/world-health-day/en/ (accessed on 20 January 2019).
  3. Kirsch, I.; Deacon, B.J.; Huedo-Medina, T.B.; Scoboria, A.; Moore, T.; Johnson, B. Initial severity and antidepressant benefits: A meta-analysis of data submitted to the Food and Drug Administration. PLoS Med. 2008, 5, e45. [Google Scholar] [CrossRef] [PubMed]
  4. Turner, E.H.; Matthews, A.M.; Linardatos, E. Selective publication of antidepressant trials and its influence on apparent efficacy. N. Engl. J. Med. 2008, 358, 252–260. [Google Scholar] [CrossRef] [PubMed]
  5. Leichsenring, F.; Steinert, C.; Hoyer, J. Psychotherapy versus pharmacotherapy of depression: What’s the evidence? Z. Psychosom. Med. Psychother. 2016, 62, 190–195. [Google Scholar] [CrossRef] [PubMed]
  6. Pigott, E.; Leventhal, M.; Alter, G.; Boren, J. Efficacy and effectiveness of antidepressants: Current status of research. Psychother. Psychosom. 2010, 79, 267–279. [Google Scholar] [CrossRef] [PubMed]
  7. Jakobsen, C.; Hansen, L.; Simonsen, E.; Gluud, C. The effect of adding psychodynamic therapy to antidepressants in patients with major depressive disorder. A systematic review of randomized clinical trials with meta-analyses and trial sequential analyses. J. Affect. Disord. 2012, 137, 4–14. [Google Scholar] [CrossRef] [PubMed]
  8. Jakobsen, J.C.; Hansen, J.L.; Storebø, O.J.; Simonsen, E.; Gluud, C. The effects of cognitive therapy versus ‘no intervention’ for major depressive disorder. PLoS ONE 2011, 6, e28299. [Google Scholar] [CrossRef] [PubMed]
  9. Zou, L.; Yeung, A.; Li, C.; Wei, G.X.; Chen, K.W.; Kinser, P.A.; Chan, J.; Ren, Z. Effects of Meditative Movements on Major Depressive Disorder: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J. Clin. Med. 2018, 7, 195. [Google Scholar] [CrossRef] [PubMed]
  10. Zou, L.; Wang, C.; Chen, X.; Wang, H. Baduanjin exercise for stroke rehabilitation: A systematic review with meta-analysis of randomized controlled trials. Int. J. Environ. Res. Public Health 2018, 15, 600. [Google Scholar] [CrossRef] [PubMed]
  11. Zou, L.; Yeung, A.; Quan, X.; Hui, S.; Hu, X.; Chan, J.; Wang, C.; Boyden, S.; Sun, L.; Wang, H. Mindfulness-based Baduanjin exercise for depression and anxiety in people with physical or mental illnesses: A systematic review and meta-analysis of randomized controlled trials. Int. J. Environ. Res. Public Health 2018, 15, 321. [Google Scholar] [CrossRef] [PubMed]
  12. Zou, L.; Yeung, A.; Quan, X.; Boyden, S.D.; Wang, H. A systematic review and meta-analysis of mindfulness-based (Baduanjin) exercise for alleviating musculoskeletal pain and improving sleep quality in people with chronic diseases. Int. J. Environ. Res. Public Health 2018, 15, 206. [Google Scholar] [CrossRef] [PubMed]
  13. Zou, L.; Cui, Y.; Li, T. Effect of Health-Qigong on spinal mobility and disease activity in people with ankylosing spondylitis. Trav. Hum. 2017, 80, 1585–1597. [Google Scholar]
  14. Zou, L.; Pan, Z.; Yeung, A.; Talwar, S.; Wang, C.; Liu, Y.; Shu, Y.; Chen, X.; Thomas, G.A. A review study on the beneficial effects of Baduanjin. J. Altern. Complment. Med. 2017, 24, 324–335. [Google Scholar] [CrossRef] [PubMed]
  15. Liu, T.J.; Chen, K.W. Chinese Medical Qigong (College Textbook); Singing Dragon: London, UK; Philadelphia, PA, USA, 2010. [Google Scholar]
  16. Zou, L.; Zhang, Y.J.; Liu, Y.; Tian, X.P.; Xiao, T.; Liu, X.L.; Yeung, A.; Liu, J.; Wang, W.Q.; Yang, Q. The Effects of Tai Chi Chuan Versus Core Stability Training on Lower-Limb Neuromuscular Function in Aging Individuals with Non-Specific Chronic Lower Back Pain. Medicina 2019, 55, 60. [Google Scholar] [CrossRef] [PubMed]
  17. Zou, L.; Wang, H.; Yu, D. Effect of a long-term modified Tai Chi-based intervention in attenuating bone mineral density in postmenopausal women in southeast China: Study protocol for a randomized controlled trial. Clin. Trials Degener. Dis. 2017, 2, 46–52. [Google Scholar]
  18. Zou, L.; Wang, C.; Tian, Z.; Wang, Z.; Shu, Y. Effect of Yang-Style Tai Chi on gait parameters and musculoskeletal flexibility in healthy Chinese older women. Sports 2017, 5, 52. [Google Scholar] [CrossRef] [PubMed]
  19. Zou, L.; Wang, H.; Xiao, Z. Tai chi for health benefits in patients with multiple sclerosis: A systematic review. PLOS ONE 2017, 12, e0170212. [Google Scholar] [CrossRef] [PubMed]
  20. Zou, L.; SasaKi, J.; Wang, H. A systematic review and meta-analysis Baduanjin Qigong for health benefits: Randomized controlled trials. Evid. Based Cmplement. Alternat. Med. 2017, 2017, e4548706. [Google Scholar] [CrossRef] [PubMed]
  21. Zou, L.; Han, J.; Tsang, W.; Yeung, A.; Hui, S.S.; Tsang, W.W.N.; Ren, Z.; Wang, L. Effects of Tai Chi on lower limb proprioception in adults aged over 55: A systematic review ad meta-analysis. Arch. Phys. Med. Rehabil. 2018. [Google Scholar] [CrossRef] [PubMed]
  22. Zou, L.; Wang, H.; Li, T. Traditional Chinese exercise intervention improves symptoms in a patient with ankylosing spondylitis: A case study. Int. J. Adv. Res. 2017, 5, 888–895. [Google Scholar] [CrossRef]
  23. Zou, L.; Sasaki, J.; Zeng, N.; Wang, C.; Sun, L. A Systematic Review with Meta-Analysis of Mindful Exercises on Rehabilitative Outcomes among post-stroke patients. Arch. Phys. Med. Rehabil. 2018, 99, 2355–2364. [Google Scholar] [CrossRef] [PubMed]
  24. Liu, J.; Yeung, A.; Xiao, T.; Tian, X.; Kong, Z.; Zou, L.; Wang, X. Chen-Style Tai Chi for Individuals (Aged 50 Years Old or Above) with Chronic Non-Specific Low Back Pain: A Randomized Controlled Trial. Int. J. Environ. Res. Public Health 2019, 16, 517. [Google Scholar] [CrossRef] [PubMed]
  25. Liu, J.; Xie, H.; Liu, M.; Wang, Z.; Zou, L.; Yeung, A.S.; Hui, S.-C.; Yang, Q. The Effects of Tai Chi on Heart Rate Variability in Older Chinese Individuals with Depression. Int. J. Environ. Res. Public Health 2018, 15, 2771. [Google Scholar] [CrossRef] [PubMed]
  26. Kachan, D.; Olano, H.; Tannenbaum, S.L.; Annane, D.W.; Mehta, A.; Arheart, K.L.; Fleming, L.E.; Yang, X.; McClure, L.A.; Lee, D.J. Prevalence of mindfulness practices in the US Workforce: National Health Interview Survey. Prev. Chronic. Dis. 2017, 14, 160034. [Google Scholar] [CrossRef] [PubMed]
  27. Yeung, A.; Chan, J.; Cheung, J.; Zou, L. Qigong and Tai-Chi for mood regulation. Focus Am. Psychiatr. Publ. 2018, 16, 40–47. [Google Scholar] [CrossRef]
  28. Taylor, E.; Taylor-Piliae, R. The effects of Tai Chi on physical and psychosocial function among persons with multiple sclerosis: A systematic review. Complement. Ther. Med. 2017, 31, 100–108. [Google Scholar] [CrossRef] [PubMed]
  29. Lee, E.; Kim, Y.; Chuang, W.; Lee, M.S. Tai Chi for disease activity and flexibility in patients with ankylosing spondylitis—A controlled clinical trial. Evid. Based Cmplement. Alternat. Med. 2008, 5, 457–462. [Google Scholar] [CrossRef] [PubMed]
  30. Lee, M.; Pittler, M.; Shin, B.; Ernst, E. Tai Chi for osteoporosis: A systematic review. Osteoporos. Int. 2008, 19, 139–146. [Google Scholar] [CrossRef] [PubMed]
  31. Bai, Z.; Guan, Z.; Fan, Y.; Liu, C.; Yang, K.; Ma, B.; Wu, B. The effects of Qigong for adults with chronic pain: Systematic review and meta-analysis. Am. J. Chin. Med. 2015, 43, 1525–1539. [Google Scholar] [CrossRef] [PubMed]
  32. Oh, B.; Choic, S.; Inamor, A.; Rosenthal, D.; Yeung, A. Effects of Qigong on depression: A systematic review. Evid. Based Complement. Alternat. Med. 2013, 2013, e134737. [Google Scholar] [CrossRef] [PubMed]
  33. Abbott, R.; Lavretsky, H. Tai Chi and Qigong for the treatment and prevention of mental disorders. Psychiatric. Clin. N. Am. 2013, 36, 109–119. [Google Scholar]
  34. Zou, L.; Sasaki, J.E.; Wei, G.-X.; Huang, T.; Yeung, A.S.; Neto, O.B.; Chen, K.W.; Hui, S.-C. Effects of Mind–Body Exercises (Tai Chi/Yoga) on Heart Rate Variability Parameters and Perceived Stress: A Systematic Review with Meta-Analysis of Randomized Controlled Trials. J. Clin. Med. 2018, 7, 404. [Google Scholar] [CrossRef] [PubMed]
  35. Chan, J.; Ho, R.; Chung, K.; Chong, W.; Yao, T.; Ng, S.; Chan, C. Qigong exercise alleviates fatigue, anxiety, and depressive symptoms, improves sleep quality, and shortens sleep latency in persons with chronic fatigue syndrome-like illness. Evid. Based Complement. Alternat. Med. 2014, 2014, e106048. [Google Scholar] [CrossRef] [PubMed]
  36. Moher, D.; Shamseer, L.; Clarke, M.; Ghersi, D.; Liberati, A.; Petticrew, M.; Shekelle, P.; Stewart, L.; PRISMA-Group. Preferred Reporting Items for Systematic Review and Meta-Analysis protocols (PRISMA) 2015 statement. PLoS Med. 2009, 6, e1000097. [Google Scholar]
  37. Zhang, Y.; Li, C.; Zou, L.; Liu, X.; Song, W. The Effects of Mind-Body Exercise on Cognitive Performance in Elderly: A Systematic Review and Meta-Analysis. Int. J. Environ. Res. Public Health 2018, 15, 2791. [Google Scholar] [CrossRef] [PubMed]
  38. Lawlor, D.; Hopker, S. The effectiveness of exercise as an intervention in the management of depression: A systematic review and meta-regression analysis of randomized controlled trials. BMJ 2001, 322, 763. [Google Scholar] [CrossRef]
  39. Tsang, H.; Chan, E.; Cheung, W. Effects of mindful and non-mindful exercises on people with depression: A systematic review. Br. J. Clin. Psychol. 2008, 47, 302–322. [Google Scholar] [CrossRef] [PubMed]
  40. Hewitt, C.; Hahn, S.; Torgerson, D.J.; Waston, J.; Bland, J.M. Adequacy and reporting of allocation concealment: Review of recent trials published in four general medical journals. BMJ 2005, 330, 1057–1058. [Google Scholar] [CrossRef] [PubMed]
  41. Yeung, A.; Feng, R.; Kim, D.; Wayne, P.; Yeh, G.; Baer, L.; Lee, O.; Denninger, J.; Fricchione, G.; Alpert, J.; Fava, M. A pilot, randomized controlled study of Tai Chi with passive and active controls in the treatment of depressed Chinese Americans. J. Clin. Psychiatry 2017, 78, e522–e528. [Google Scholar] [CrossRef] [PubMed]
  42. Chan, A.; Wong, Q.; Sze, S. A Chinese Chan-based mind-body intervention for patients with depression. J. Affect. Disord. 2012, 142, 283–289. [Google Scholar] [CrossRef] [PubMed]
  43. Williams, J.B. A structured interview guide for the Hamilton Depression Rating Scale. Arch. Gener. Psychiatry 1988, 45, 742–747. [Google Scholar] [CrossRef]
  44. Egger, M.; Smith, G.; Minder, C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315, 629–634. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Yeung, A.; Lepoutre, V.; Wayne, P.; Yeh, G.; Slipp, L.; Fava, M.; Denninger, J.; Benson, H.; Fricchione, G. Tai Chi treatment for depression in Chinese Americans: A pilot study. Am. J. Phys. Med. Rehabil. 2012, 91, 863–870. [Google Scholar] [CrossRef] [PubMed]
  46. Lavretsky, H.; Alstein, L.; Ercoli, O.; RIparetti-Brown, M.; Cyr, N.; Irwin, M. Complementary use of Tai Chi Chih augments escitalopram treatment of geriatric depression: A randomized controlled trial. Am. J. Geriatr. Psychiatry 2011, 19, 839–850. [Google Scholar] [CrossRef] [PubMed]
  47. Chou, K.; Lee, P.; Yu, E.; Macfarlane, D.; Cheng, Y.; Chan, S.; Chi, I. Effect of Tai Chi on depressive symptoms amongst Chinese older patients with depressive disorders: A randomized clinical trial. Int. J. Geriatr. Psychiatry 2004, 19, 1105–1107. [Google Scholar] [CrossRef] [PubMed]
  48. Costa, A.; Barnhofer, T. Turning towards or turning away: A comparison of mindfulness meditation and guided imagery relaxation in patients with acute depression. Behav. Cognit. Psychother. 2016, 44, 410–419. [Google Scholar] [CrossRef] [PubMed]
  49. Fissler, M.; Winnebeck, E.; Schroeter, T.; Gummersbach, M.; Huntenburg, J.; Gaertner, M.; Barnhofer, T. An investigation of the effects of brief mindfulness training on self-reported interoceptive awareness, the ability to decenter, and their role in the reduction of depressive symptoms. Mindfulness 2016, 7, 1170–1181. [Google Scholar] [CrossRef]
  50. Matos, L.; Sousa, C.; Gonçalves, M. Qigong as a traditional vegetative biofeedback therapy: Long-term conditioning of physiological mind-body effects. BioMed Res. Int. 2015, 2015, e531789. [Google Scholar] [CrossRef] [PubMed]
Ijerph 16 00826 g001 550
Figure 1. The process of study identification, screening, and selection.
Figure 1. The process of study identification, screening, and selection.
Ijerph 16 00826 g001
Ijerph 16 00826 g002 550
Figure 2. Effects of Qigong on depression severity. Note: HAM-D24 = 24-item Hamilton Depression Rating Scale, HAM-D17 = 17-item Hamilton Depression Rating Scale, CES-D = Epidemiological Studies Depression Scale, BDI = Beck Depression Inventory. HE = heath education, WL = waitlist, CBT = cognitive behavioral therapy, GI = guided imagery, RM = rest and music.
Figure 2. Effects of Qigong on depression severity. Note: HAM-D24 = 24-item Hamilton Depression Rating Scale, HAM-D17 = 17-item Hamilton Depression Rating Scale, CES-D = Epidemiological Studies Depression Scale, BDI = Beck Depression Inventory. HE = heath education, WL = waitlist, CBT = cognitive behavioral therapy, GI = guided imagery, RM = rest and music.
Ijerph 16 00826 g002
Table
Table 1. Characteristics of the eligible randomized controlled trials.
Table 1. Characteristics of the eligible randomized controlled trials.
ReferenceCharacteristics of ParticipantsIntervention ProtocolOutcome MeasuredStudy Quality
Patients Diagnostic Criteria, % of MDD,
Study Location		Total Sample Size (DR), Female (%),
Predominant Ethnicity		Age:
Mean (SD)		Training PrescriptionTotal Training MinGrp or IndCo-interventionOutcomes
(Instrument)		Concealed AllocationIntention to Treat AnalysisBlinded
Yeung et al. (2017) [41]DSM-IV (psychiatrist),
100% of MDD, USA		67 (25.3%), 72% female,
100% Chinese Americans		54 (13)Q: 2 × 60 min/week, 12 weeks
(12 weeks follow-up) (Tai Chi);
C1: 2 × 60 min/week (health education); C2: wait-list		1440GrpNoneRemission rate, response rate, depression severity
(HAM-D17 and BDI)		NoYesNo
Chan et al. (2012) [42]DSM-IV-TR (psychiatrist),
100% of MDD,
China (HK)		75 (33.3%), 80% female, 100% ChineseQ: 47.1 (9.5)
C1: 46.9 (6.5)
C2: 45.4 (8.3)		Q:1 × 90 min/week 10 weeks
(Shaolin movement Qigong);
C1: 1 x× 90 min/week
(CBT); C2: wait-list		900GrpAntidepressantsDepression severity
(HAM-D17 and BDI)		YesNoYes
Yeung et al. (2012) [45]DSM-IV (psychiatrist),
100% of MDD, USA		39 (5.1%), 77% female,
100% Chinese Americans		55(10)Q: 2 × 60 min/week, 12 weeks
(Tai Chi); C: wait-list		1440GrpAntidepressants allowedRemission rate, response rate,
depression severity (HAM-D17)		YesYesYes
Lavretsky et al. (2011) [46]DSM-IV (psychiatrist),
100% of MDD, USA		73 (6.8%), 61.6% female,
74% Caucasians and 11% African-Americans		Q: 69.1 (7.0)
C: 72.0 (7.4)		Q: 1 × 120 min/week, 10 weeks
(Tai Chi); C: 1 × 120 min/week (health education)		1200GrpEscitalopram/lorazepam: 10–20 mg/dayDepression severity (HAM-D24)YesYesYes
Chou et al. (2004) [47]DSM-IV (psychiatrist),
90% of MDD, China (HK)		14 (0%), 50% female,
100% Chinese		72.6 (4.2)Q: 3 × 45 min/week, 12 weeks
(Tai Chi); C: wait-list		1620GrpAntidepressants or psychotherapyDepression severity
(CES-D)		NoYesYes
Costa et al. (2016) [48]DSM-IV (psychiatrist),
100% of MDD, UK		40 (7.5%), 74% female,
74% Caucasians and 16% African-Americans		Q: 39 (1.2)
C: 38 (9.7)		Q: 1 × 60min/week (Grp) +
6 × 30 min/week (Ind), 1 week
(static Qigong);
C: same dosage/format (guided imagery)		240MixedAntidepressantsDepression severity (BDI)YesNoNo
Fissler et al. (2016) [49]DSM-IV (a psychiatrist),
100% of MDD,
Germany		74 (8.1%), 56% female,
100% Caucasians		42 (12.5)Q: 7 × 50 min/week, 2 weeks
(Static Qigong); C: 7 × 50 min/week (rest and music)		700GrpAntidepressantsDepression severity
(BDI)		YesNoNo
Note: MDD = major depressive disorder; DR = dropout rate; FU = follow-up period; AE = adverse event; SD = standard deviation; Q = Qigong group; C = control group; HK = Hong Kong; DSM-IV = Diagnostic and Statistical Manual of Mental Disorders; Grp = group based practice; Ind = individual practice; CES-D = Epidemiological Studies Depression Scale; HAM-D17 = 17-item Hamilton Depression Rating Scale; BDI = Beck Depression Inventory; HAM-D24 = 24-Item Hamilton Depression Rating Scale; Remission rate = HAM-D17 scores ≤ 7; Response rate = ≥ 50% improvement on the HAM-D17 score; CBT = cognitive behavioral therapy.
Table
Table 2. Moderator analysis for Qigong versus control group.
Table 2. Moderator analysis for Qigong versus control group.
Categorical ModeratorOutcomeLevelNo. of Studies/
Comparisons		Hedges’ g95% CII2 %Test for Between-Group
Homogeneity
Q-Valuedf (Q)p-Value
Control TypeDepressionActive4−0.47−0.81 to −0.1222.75%1.4110.23
Passive5−0.80−1.23 to −0.3748.07%
Qigong TypeDepressionMovement7−0.62−0.96 to −0.2841.62%0.0210.9
Static2−0.67−1.38 to 0.0467.84%

Share and Cite

MDPI and ACS Style

Guo, L.; Kong, Z.; Zhang, Y. Qigong-Based Therapy for Treating Adults with Major Depressive Disorder: A Meta-Analysis of Randomized Controlled Trials. Int. J. Environ. Res. Public Health 2019, 16, 826. https://doi.org/10.3390/ijerph16050826

AMA Style

Guo L, Kong Z, Zhang Y. Qigong-Based Therapy for Treating Adults with Major Depressive Disorder: A Meta-Analysis of Randomized Controlled Trials. International Journal of Environmental Research and Public Health. 2019; 16(5):826. https://doi.org/10.3390/ijerph16050826

Chicago/Turabian Style

Guo, Lijuan, Zhaowei Kong, and Yanjie Zhang. 2019. "Qigong-Based Therapy for Treating Adults with Major Depressive Disorder: A Meta-Analysis of Randomized Controlled Trials" International Journal of Environmental Research and Public Health 16, no. 5: 826. https://doi.org/10.3390/ijerph16050826

APA Style

Guo, L., Kong, Z., & Zhang, Y. (2019). Qigong-Based Therapy for Treating Adults with Major Depressive Disorder: A Meta-Analysis of Randomized Controlled Trials. International Journal of Environmental Research and Public Health, 16(5), 826. https://doi.org/10.3390/ijerph16050826

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop